C
Cytomx Therapeutics (CTMX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Cytomx Therapeutics (CTMX)
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeuti... Read more
- USD2.27
- USD2.30
- USD2.10
- USD2.55
- 205.40%
- 148M
- 3.74M
- 12.10M
- 351M
- 0.40
- 21.90%
Stock News
yesterday
Nvidia’s earnings are the stock market’s next major test after May’s Big Tech comeback
MarketWatch
yesterday
ONEOK to Participate in Investor Conference
Yahoo
yesterday
Nvidia's feverish recovery rally faces a reality check. What investors should know
CNBC
yesterday
Every portfolio stock is higher in Tuesday's market rally. Here's our top performer
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
